{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:08:44Z","timestamp":1788570524185,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.06.091","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T20:10:15Z","timestamp":1436040615000},"page":"3843-3849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine"],"prefix":"10.1016","volume":"33","author":[{"given":"C\u00e9cile","family":"Sigoillot-Claude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Battaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fiorucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Vimort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Vaganay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Poulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.06.091_bib0180","series-title":"Laboratory techniques in rabies","first-page":"279","article-title":"The NIH test for potency","author":"Seligmann","year":"1973"},{"issue":"5","key":"10.1016\/j.vaccine.2015.06.091_bib0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biologicals.2012.07.005","article-title":"Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: State of the science and planning the way forward","volume":"40","author":"Stokes","year":"2012","journal-title":"Biologicals"},{"issue":"4","key":"10.1016\/j.vaccine.2015.06.091_bib0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.biologicals.2014.04.001","article-title":"Replacing the NIH test for rabies vaccine potency testing: a synopsis of drivers and barriers","volume":"42","author":"Schiffelers","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2015.06.091_bib0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01310002","article-title":"Role of phospholipids in rhabdovirus attachment to CER cells","volume":"81","author":"Superti","year":"1984","journal-title":"Brief Rep Arch Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2015.06.091_bib0200","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1099\/0022-1317-77-10-2437","article-title":"Rabies virus binding to the nicotinic acetylcholine receptor alpha subunit demonstrated by virus overlay protein binding assay","volume":"77","author":"Gastka","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.06.091_bib0205","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1128\/JVI.72.9.7181-7190.1998","article-title":"The neural cell adhesion molecule is a receptor for rabies virus","volume":"72","author":"Thoulouze","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.06.091_bib0210","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1093\/emboj\/17.24.7250","article-title":"Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus","volume":"17","author":"Tuffereau","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2015.06.091_bib0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.06.091_bib0220","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0264-410X(85)90224-5","article-title":"Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies","volume":"3","author":"Perrin","year":"1985","journal-title":"Vaccine"},{"issue":"Nov (22)","key":"10.1016\/j.vaccine.2015.06.091_bib0225","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM199311253292208","article-title":"Rabies","volume":"329","author":"Fishbein","year":"1993","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2015.06.091_bib0230","doi-asserted-by":"crossref","first-page":"S771","DOI":"10.1093\/clinids\/10.Supplement_4.S771","article-title":"The molecular biology of rabies viruses","volume":"10","author":"Wunner","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.091_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0042-6822(85)90440-4","article-title":"Antigenic variants of CVS rabies virus with altered glycosylation sites","volume":"140","author":"Wunner","year":"1985","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2015.06.091_bib0240","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/glycob\/cwi046","article-title":"N-glycosylation at one rabies virus glycoprotein sequon influences N-glycan processing at a distant sequon on the same molecule","volume":"15","author":"Wojczyk","year":"2005","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.091_bib0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1045-1056(02)00070-2","article-title":"Inactivated rabies vaccine control and release: use of an ELISA method","volume":"31","author":"Fournier-Caruana","year":"2003","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.091_bib0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","article-title":"A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture","volume":"34","author":"Nagarajan","year":"2006","journal-title":"Biologicals"},{"issue":"50","key":"10.1016\/j.vaccine.2015.06.091_bib0255","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1016\/j.vaccine.2013.10.019","article-title":"A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release","volume":"31","author":"Gibert","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.06.091_bib0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/biol.1996.0012","article-title":"Use of ELISA for in vitro potency test of rabies vaccines for animal use","volume":"24","author":"Gamoh","year":"1996","journal-title":"Biologicals"},{"issue":"2, 3","key":"10.1016\/j.vaccine.2015.06.091_bib0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.vaccine.2013.11.026","article-title":"A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use","volume":"32","author":"Abhinay","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.091_bib0270","first-page":"17","article-title":"Establishment of batch 4 of the biological reference preparation (BRP) for rabies vaccine (inactivated) for veterinary use","volume":"2004","author":"Daas","year":"2004","journal-title":"Pharmeuropa Bio"},{"key":"10.1016\/j.vaccine.2015.06.091_bib0275","series-title":"Laboratory techniques in rabies","first-page":"133","article-title":"Technique for the production, screening and characterization of monoclonals antibodies","author":"Lafon","year":"1996"},{"issue":"3","key":"10.1016\/j.vaccine.2015.06.091_bib0280","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0022-1759(79)90098-X","article-title":"Periodate or glutaraldyehyde for preparing peroxidase conjugates?","volume":"30","author":"Boorsma","year":"1979","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.091_bib0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.06.091_bib0290","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/biol.1994.1036","article-title":"Calibration of a replacement preparation for the international standard for rabies immunoglobulin rabies IgG IS","volume":"22","author":"Lyng","year":"1994","journal-title":"Biologicals"},{"issue":"7","key":"10.1016\/j.vaccine.2015.06.091_bib0295","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1099\/0022-1317-80-7-1647","article-title":"Soluble ectodomain of rabies virus glycoprotein expressed in eukaryotic cells folds in a monomeric conformation that is antigenically distinct from the native state of the complete, membrane-anchored glycoprotein","volume":"80","author":"Gaudin","year":"1999","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.091_bib0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/viro.2002.1429","article-title":"Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers","volume":"297","author":"Roche","year":"2002","journal-title":"Virology"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2015.06.091_bib0305","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jviromet.2009.01.017","article-title":"Potency evaluation of rabies vaccine for human use: the impact of the reduction in the number of animals per dilution","volume":"158","author":"de Moura","year":"2009","journal-title":"J Virol Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2015.06.091_bib0310","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/JVI.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.06.091_bib0315","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/JVI.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.091_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.62.1.1-7.1988","article-title":"Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence","volume":"62","author":"Prehaud","year":"1988","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.06.091_bib0325","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/JVI.67.3.1365-1372.1993","article-title":"Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion","volume":"67","author":"Gaudin","year":"1993","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2015.06.091_bib0330","first-page":"407","article-title":"Structure de la glycoproteine des rhabdovirus","volume":"12","author":"Albertini","year":"2008","journal-title":"Virologie"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2015.06.091_bib0335","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0264-410X(98)00357-0","article-title":"Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?","volume":"17","author":"Drings","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2015.06.091_bib0340","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1099\/0022-1317-83-6-1465","article-title":"Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type","volume":"83","author":"Maillard","year":"2002","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.06.091_bib0345","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0042-6822(81)90435-9","article-title":"Production of spikeless particles of the rabies virus under conditions of low pH","volume":"108","author":"Kawai","year":"1981","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2015.06.091_bib0350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biologicals.2010.12.001","article-title":"The consistency approach for quality control of vaccines\u2014a strategy to improve quality control and implement 3Rs","volume":"39","author":"De Mattia","year":"2011","journal-title":"Biologicals"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:50:00Z","timestamp":1691801400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15009068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":35,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15009068"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.091","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}